Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically Hepatitis C virus-infected individuals

Journal of Virology

Volumn 88, Issue 13, 2014, Pages 7678-7682

  Nonnenmann, Julia ^a   Stirner, Renate ^a   Roider, Julia ^a   Jung, Maria C ^b   Schrödl, Kathrin ^a   Bogner, Johannes R ^a   Draenert, Rika ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Leberzentrum Prof Dr Jung und Dr Fischer   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ARTICLE; BLOOD; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS GENOTYPE C; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; VIRUS LOAD; ANTIGEN PRESENTATION; CASE CONTROL STUDY; CHRONIC HEPATITIS C; COMPARATIVE STUDY; FLOW CYTOMETRY; GENETICS; HEPACIVIRUS; IMMUNOLOGY; IMMUNOPHENOTYPING; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; METABOLISM; VIROLOGY;

ANTIGEN PRESENTATION; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; MYELOID CELLS; VIRAL LOAD;

EID: 84901992636     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00113-14     Document Type: Article

References (14)

1. Greten TF, Manns MP, Korangy F. 2011. Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol. 11:802-807. http://dx .doi.org/10.1016/j.intimp.2011.01.003.
2. Khaled YS, Ammori BJ, Elkord E. 2013. Myeloid-derived suppressor cells in cancer: recent progress and prospects. Immunol. Cell Biol. 91:493-502. http://dx.doi.org/10.1038/icb.2013.29.
3. Vollbrecht T, Stirner R, Tufman A, Roider J, Huber RM, Bogner JR, Lechner A, Bourquin C, Draenert R. 2012. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 26:F31-F37. http://dx.doi.org/10.1097/QAD.0b013e328354b43f.
4. Qin A, Cai W, Pan T, Wu K, Yang Q, Wang N, Liu Y, Yan D, Hu F, Guo P, Chen X, Chen L, Zhang H, Tang X, Zhou J. 2013. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J. Virol. 87:1477-1490. http://dx.doi.org /10.1128/JVI.01759-12.
5. Larrubia JR, Benito-Martinez S, Miquel J, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. 2009. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C. World J. Gastroenterol. 15:5129-5140. http://dx.doi.org/10.3748/wjg .15.5129.
6. Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Kruger C, Manns MP, Greten TF, Korangy F. 2008. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 135:234-243. http: //dx.doi.org/10.1053/j.gastro.2008.03.020.
7. Tacke RS, Lee HC, Goh C, Courtney J, Polyak SJ, Rosen HR, Hahn YS.2012. Myeloid suppressor cells induced by hepatitis C virus suppress T cell responses through the production of reactive oxygen species. Hepatology 55:343-353. http://dx.doi.org/10.1002/hep.24700.
8. Cai W, Qin A, Guo P, Yan D, Hu F, Yang Q, Xu M, Fu Y, Zhou J, Tang X. 2013. Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients. J. Clin. Immunol. 33:798-808. http://dx.doi.org/10.1007/s10875-012-9861-2.
9. Kotsakis A, Harasymczuk M, Schilling B, Georgoulias V, Argiris A, Whiteside TL. 2012. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J. Immunol. Methods 381:14-22. http://dx.doi.org/10.1016/j.jim.2012.04.004.
10. Trellakis S, Bruderek K, Hutte J, Elian M, Hoffmann TK, Lang S, Brandau S. 2013. Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer. Innate Immun. 19:328-36. http://dx.doi.org/10.1177/1753425912463618.
11. Rieber N, Brand A, Hector A, Graepler-Mainka U, Ost M, Schafer I, Wecker I, Neri D, Wirth A, Mays L, Zundel S, Fuchs J, Handgretinger R, Stern M, Hogardt M, Doring G, Riethmuller J, Kormann M, Hartl D. 2013. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J. Immunol. 190:1276-1284. http://dx.doi.org/10.4049 /jimmunol.1202144.
12. Rieber N, Gille C, Kostlin N, Schafer I, Spring B, Ost M, Spieles H, Kugel HA, Pfeiffer M, Heininger V, Alkhaled M, Hector A, Mays L, Kormann M, Zundel S, Fuchs J, Handgretinger R, Poets CF, Hartl D.2013. Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses. Clin. Exp. Immunol. 174: 45-52. http://dx.doi.org/10.1111/cei.12143.
13. Mandruzzato S, Solito S, Falisi E, Francescato S, Chiarion-Sileni V, Mocellin S, Zanon A, Rossi CR, Nitti D, Bronte V, Zanovello P. 2009. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. J. Immunol. 182:6562-6568. http://dx.doi.org/10.4049/jimmunol .0803831.
14. Verschoor CP, Johnstone J, Millar J, Dorrington MG, Habibagahi M, Lelic A, Loeb M, Bramson JL, Bowdish DM. 2013. Blood CD33(+)HLADR(-) myeloid-derived suppressor cells are increased with age and a history of cancer. J. Leukoc. Biol. 93:633-637. http://dx.doi.org/10.1189/jlb .0912461.